Applied DNA Sciences Inc (APDN)
1.21
+0.01
(+0.83%)
USD |
NASDAQ |
Sep 29, 16:00
1.21
0.00 (0.00%)
After-Hours: 20:00
Applied DNA Sciences Cash from Financing (TTM)
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| September 30, 2021 | 14.70M |
| June 30, 2021 | 15.56M |
| March 31, 2021 | 20.84M |
| December 31, 2020 | 9.539M |
| September 30, 2020 | 19.43M |
| June 30, 2020 | 20.41M |
| March 31, 2020 | 15.38M |
| December 31, 2019 | 13.62M |
| September 30, 2019 | 5.829M |
| June 30, 2019 | 5.651M |
| March 31, 2019 | 5.398M |
| December 31, 2018 | 4.501M |
| September 30, 2018 | 5.883M |
| June 30, 2018 | 5.738M |
| March 31, 2018 | 6.004M |
| December 31, 2017 | 6.197M |
| September 30, 2017 | 6.105M |
| June 30, 2017 | 4.586M |
| March 31, 2017 | 4.320M |
| December 31, 2016 | 4.320M |
| September 30, 2016 | 7.844M |
| June 30, 2016 | 7.858M |
| March 31, 2016 | 19.09M |
| December 31, 2015 | 19.02M |
| September 30, 2015 | 15.02M |
| Date | Value |
|---|---|
| June 30, 2015 | 16.65M |
| March 31, 2015 | 7.571M |
| December 31, 2014 | 7.640M |
| September 30, 2014 | 3.775M |
| June 30, 2014 | 9.271M |
| March 31, 2014 | 7.126M |
| December 31, 2013 | 12.73M |
| September 30, 2013 | 14.73M |
| June 30, 2013 | 8.160M |
| March 31, 2013 | 9.701M |
| December 31, 2012 | 4.101M |
| September 30, 2012 | 2.101M |
| June 30, 2012 | 5.928M |
| March 31, 2012 | 4.985M |
| December 31, 2011 | 5.66M |
| September 30, 2011 | 6.580M |
| June 30, 2011 | 3.118M |
| March 31, 2011 | 2.976M |
| December 31, 2010 | 2.800M |
| September 30, 2010 | 2.260M |
| June 30, 2010 | 2.165M |
| March 31, 2010 | 2.175M |
| December 31, 2009 | 2.425M |
| September 30, 2009 | 2.546M |
| June 30, 2009 | 1.845M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
4.501M
Minimum
Dec 2018
20.84M
Maximum
Mar 2021
12.57M
Average
14.16M
Median
Cash from Financing (TTM) Benchmarks
| Fonar Corp | -7.572M |
| XWELL Inc | -10.99M |
| ProPhase Labs Inc | -10.99M |
| OncoCyte Corp | 11.62M |
| Exagen Inc | -10.50M |